Drug Giant Faced a Reckoning as China Took Aim at Bribery. China, Barboza, David, GlaxoSmithKline PLC, Bribery and Kickbacks, Frauds and Swindling, Whistle-Blowers, Fines (Penalties), Humphrey, Peter, Reilly, Mark, Shi, Vivian, ChinaWhys, Series